Dr Salil Vengalil

Dr Salil Vengalil
Salil
Vengalil
MBBS, MRCP, FRCR, Consultant Clinical Oncologist

Languages spoken

English & Malayalam

Expert in

Oncological treatment of patients with prostate cancer

Overview

Centres

Birmingham
Birmingham

Little Aston Hall Drive, Sutton Coldfield, B74 3BF

52.60208, -1.87412
/uk/our-centres/birmingham
+44 (0) 121 353 3055
mediahawkNumber3664 mhMobile

Specialises in

Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate cancer
Skin cancer
Condition
Condition/Cancer
Condition/Cancer/Non-melanoma skin cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy
Image-guided radiotherapy (IGRT)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Image-guided radiotherapy
Intensity modulated radiotherapy (IMRT)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Intensity modulated radiotherapy
Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Stereotactic ablative radiotherapy (SABR)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Stereotactic ablative radiotherapy (SABR)

Special clinical interest in prostate, bladder, kidney, lung and Mesothelioma, Melanoma and non-melanoma skin cancers

Dr Salil Vengalil has been working as Consultant Clinical Oncologist at the University Hospital of North Midlands (UHNM) since 2013. He has expertise in oncological treatment of patients with prostate cancer, Bladder cancerKidney cancer, Lung cancer, Mesothelioma, Melanoma and non-melanoma skin cancers.

Referral Criteria: Patients requiring opinion and oncological management for the above conditions can be referred. Dr Vengalil would also be happy to accept referrals for second opinions. Private patient Consultation will be arranged at the Nuffield Health North Staffordshire Hospital.

Dr Vengalil has previously worked in the world-renowned Princess Margaret Hospital, Toronto (Canada) where he completed radiation oncology fellowship gaining further experience in advanced radiation techniques. His areas of interest in radiotherapy include Intensity modulated radiation therapy (IMRT), Image guided radiation therapy (IGRT), Stereotactic body radiotherapy (SBRT) and adaptive radiotherapy. Prostate cancer patients will also be given the option of having a spacer insertion arranged through the GenesisCare team prior to prostate radiotherapy treatment.

Dr Salil Vengalil is an expert in radiotherapy, chemotherapy, targeted therapy, immunotherapy, hormone therapy and radionuclide treatments in oncology. He has led the team in setting up and implementing Radium 223 treatment service for metastatic prostate cancer patients at UHNM. He has a very keen interest in research and had been principal investigator for several commercial and non-commercial trials.

Radiotherapy treatments will be arranged at the Genesis care radiotherapy centres or at Royal Stoke University Hospital Cancer centre. Systemic treatments will be organised mainly through Nuffield health but can also be arranged with other providers where appropriate.

Dr Vengalil had also served as a Clinical lead in Oncology at the University Hospital North Midlands NHS Trust and is currently the oncology lead for urological cancers. Dr Vengalil is also member of the West midlands Genomic Tumour Advisory Board.

Dr Salil Vengalil works with the following private medical insurance providers:

  • AXA PPP Healthcare
  • Bupa

Clinical interests

  • Prostate cancer, Bladder cancer, Kidney cancer, Lung cancer, Mesothelioma, Melanoma and non-melanoma skin cancers, Stereotactic Ablative Radiotherapy (SABR), radiotherapy, chemotherapy, systemic therapies, immunotherapy, hormone therapy and radionuclide treatments in oncology.

Research interests

  • Prostate cancer, Bladder cancer, Kidney cancer, Lung cancer, Mesothelioma, Melanoma and non-melanoma skin cancers.

Professional memberships

  • Royal College of Radiologists
  • British Medical Association
  • European Society for Medical Oncology

Accomplishments

Publications

  • Multi-modal treatment approach for muscle invasive bladder cancer – single institution experience. Poster presentation at the BLADDR 2019 meeting in Paris (October 2019)
  • Outcomes of Non-Small Cell Lung Cancer Patients with Brain Metastasis Treated by Whole Brain Radiotherapy, a Single Institution Experience: Journal of Thoracic Oncology, Volume 14, Issue 10, Supplement, Pages S949–S950
  • Virtual imaging for patient information on radiotherapy planning and delivery for prostate cancer: Radiotherapy and Oncology. April 2019; vol 133 Suppl 1: S437-38.